These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 16001645)

  • 21. [Improvement of bone metabolism after infliximab therapy in Crohn's disease].
    Miheller P; Muzes G; Zágoni T; Tóth M; Rácz K; Tulassay Z
    Orv Hetil; 2005 Jul; 146(28):1477-80. PubMed ID: 16130441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoantibody profile during short-term infliximab treatment for Crohn's disease: a prospective cohort study.
    Atzeni F; Ardizzone S; Sarzi-Puttini P; Colombo E; Maconi G; De Portu S; Carrabba M; Bianchi Porro G
    Aliment Pharmacol Ther; 2005 Sep; 22(5):453-61. PubMed ID: 16128684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of trough serum infliximab to clinical outcome after scheduled maintenance treatment for Crohn's disease.
    Maser EA; Villela R; Silverberg MS; Greenberg GR
    Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1248-54. PubMed ID: 16931170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does infliximab infusion impact results of operative treatment for Crohn's perianal fistulas?
    Gaertner WB; Decanini A; Mellgren A; Lowry AC; Goldberg SM; Madoff RD; Spencer MP
    Dis Colon Rectum; 2007 Nov; 50(11):1754-60. PubMed ID: 17899271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infliximab treatment for symptomatic Crohn's disease strictures.
    Pelletier AL; Kalisazan B; Wienckiewicz J; Bouarioua N; Soulé JC
    Aliment Pharmacol Ther; 2009 Feb; 29(3):279-85. PubMed ID: 19035967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infliximab plus azathioprine for steroid-dependent Crohn's disease patients: a randomized placebo-controlled trial.
    Lémann M; Mary JY; Duclos B; Veyrac M; Dupas JL; Delchier JC; Laharie D; Moreau J; Cadiot G; Picon L; Bourreille A; Sobahni I; Colombel JF;
    Gastroenterology; 2006 Apr; 130(4):1054-61. PubMed ID: 16618399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risks and benefits of infliximab for the treatment of Crohn's disease.
    Siegel CA; Hur C; Korzenik JR; Gazelle GS; Sands BE
    Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1017-24; quiz 976. PubMed ID: 16843733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease.
    Franchimont N; Putzeys V; Collette J; Vermeire S; Rutgeerts P; De Vos M; Van Gossum A; Franchimont D; Fiasse R; Pelckmans P; Malaise M; Belaiche J; Louis E
    Aliment Pharmacol Ther; 2004 Sep; 20(6):607-14. PubMed ID: 15352908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of response and requirement of infliximab dose intensification in Crohn's disease: a review.
    Gisbert JP; Panés J
    Am J Gastroenterol; 2009 Mar; 104(3):760-7. PubMed ID: 19174781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children.
    Hyams J; Crandall W; Kugathasan S; Griffiths A; Olson A; Johanns J; Liu G; Travers S; Heuschkel R; Markowitz J; Cohen S; Winter H; Veereman-Wauters G; Ferry G; Baldassano R;
    Gastroenterology; 2007 Mar; 132(3):863-73; quiz 1165-6. PubMed ID: 17324398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guidelines for treatment with infliximab for Crohn's disease.
    Hommes DW; Oldenburg B; van Bodegraven AA; van Hogezand RA; de Jong DJ; Romberg-Camps MJ; van der Woude J; Dijkstra G;
    Neth J Med; 2006; 64(7):219-29. PubMed ID: 16929083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical response does not correlate with intestinal or blood cyclosporine concentrations in patients with Crohn's disease treated with high-dose oral cyclosporine.
    Sandborn WJ; Tremaine WJ; Lawson GM
    Am J Gastroenterol; 1996 Jan; 91(1):37-43. PubMed ID: 8561141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type of fistula determines response to infliximab in patients with fistulous Crohn's disease.
    Parsi MA; Lashner BA; Achkar JP; Connor JT; Brzezinski A
    Am J Gastroenterol; 2004 Mar; 99(3):445-9. PubMed ID: 15056083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of concurrent elemental diet on infliximab treatment for Crohn's disease.
    Tanaka T; Takahama K; Kimura T; Mizuno T; Nagasaka M; Iwata K; Nakano H; Muramatsu M; Takazoe M
    J Gastroenterol Hepatol; 2006 Jul; 21(7):1143-9. PubMed ID: 16824066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infliximab downregulates basic fibroblast growth factor and vascular endothelial growth factor in Crohn's disease patients.
    Di Sabatino A; Ciccocioppo R; Benazzato L; Sturniolo GC; Corazza GR
    Aliment Pharmacol Ther; 2004 May; 19(9):1019-24. PubMed ID: 15113369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maintenance infliximab does not result in increased abscess development in fistulizing Crohn's disease: results from the ACCENT II study.
    Sands BE; Blank MA; Diamond RH; Barrett JP; Van Deventer SJ
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1127-36. PubMed ID: 16611273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Local injection of Infliximab for the treatment of perianal Crohn's disease.
    Poggioli G; Laureti S; Pierangeli F; Rizzello F; Ugolini F; Gionchetti P; Campieri M
    Dis Colon Rectum; 2005 Apr; 48(4):768-74. PubMed ID: 15768185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-time PCR quantification analysis of five mucosal transcripts in patients with Crohn's disease.
    Eriksson A; Jennische E; Flach CF; Jorge A; Lange S
    Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):290-6. PubMed ID: 18334872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Humoral and cellular monitoring to predict the development of infection in Crohn's disease patients beginning treatment with infliximab.
    Carbone J; Gonzalez-Lara V; Sarmiento E; Chean C; Perez JL; Marin I; Rodríguez-Molina JJ; Gil J; Fernández-Cruz E
    Ann N Y Acad Sci; 2007 Jun; 1107():346-55. PubMed ID: 17804562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Infliximab in the treatment of Crohn's disease -- a practical approach. Infliximab and chronic Crohn's disease--Consensus statement of the Working Group on Chronic Inflammatory Crohn's Diseases of the OGGH].
    Tilg H; Knoflach P; Petritsch W; Vogelsang H; Reinisch W;
    Z Gastroenterol; 2004 Oct; 42(10):1256-63. PubMed ID: 15508068
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.